levalbuterol HFA Xopenex
Selected indexed studies
- A levalbuterol metered-dose inhaler (Xopenex HFA) for asthma. (Med Lett Drugs Ther, 2006) [PMID:16543879]
- Paradoxical Bronchoconstriction with Short-Acting Beta Agonist. (Am J Case Rep, 2018) [PMID:30297688]
- A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. (J Allergy Clin Immunol, 2008) [PMID:18692886]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. (2008) pubmed
- A levalbuterol metered-dose inhaler (Xopenex HFA) for asthma. (2006) pubmed
- Paradoxical Bronchoconstriction with Short-Acting Beta Agonist. (2018) pubmed
- Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma. (2007) pubmed
- An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. (2007) pubmed